Table 1.
Outcome Assessed | Baseline N = 171 (%) |
Post-Intervention N = 250 (%) |
Significance |
---|---|---|---|
Errors of Omission | |||
Drug stated | 171 (100) | 250 (100) | - |
Indication stated | 110 (64) | 250 (100) | p < 0.05 |
Route stated | 99(58) | 250 (100) | p < 0.05 |
Clear dose stated | 89 (52) | 250 (100) | p < 0.05 |
Duration | 154 (90) | 250 (100) | p < 0.05 |
Signed and dated | 171 (100) | 250 (100) | - |
Appropriate diluent specified | 82 (48) | 250 (100) | p < 0.05 |
Appropriate dilution volume | 40 (23) | 250 (100) | p < 0.05 |
Dose ranges | |||
Prescriptions stating a dose range | 122 (71) | 179 (72) | - |
Safe dose ranges | 84 (69) | 173 (97) | p < 0.05 |
Mixing directions | |||
N of prescriptions requiring mixing directions | 154 (90) | 209 (84) | - |
Correct mixing directions | 0 (0) | 157 (75) | |
Incorrect mixing directions | 56 (25) | 1 (0.5) | p < 0.05 |
Mixing directions missing | 98 (75) | 51 (24) |